PHARMAGEN CO., LTD.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PHARMAGEN CO., LTD. - overview
Established
2008
Location
-, -, South Korea
Primary Industry
Pharmaceuticals
About
Based in Cheonan-si, South Korea, and founded in 2008, Pharmagen Co. , Ltd. operates and manufactures a wide range of medical supplies and pharmaceutical products, including pharmaceutical compounds and other items related to medicine. In March 2017, PHARMAGEN CO.
, LTD. raised KRW 6 billion in venture funding from investors GMB Investment, IBK Capital, Industrial Bank of Korea, and T. S. Investment.
The company focuses on selling drug substances used for treating dementia and supplying intermediates associated with dementia treatment and various medicine-related products, such as pharmaceutical compounds.
Current Investors
Industrial Bank of Korea, T.S. Investment, IBK Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.